Announcement

Prof. Dipanjan Chowdhury as the first incumbent of the Svanberg Family Chair at the Dana-Farber Cancer Institute!

We are pleased to announce that our long-term collaborator, Prof. Dipanjan Chowdhury, has been selected as the first incumbent of the Svanberg Family Chair within the Endowed Chairs program at Dana-Farber Cancer Institute. This distinction honors a distinguished senior faculty member and provides invaluable financial support in perpetuity to pursue research and care initiatives leading […]

Prof. Wojciech Fendler elected as President of the Polish Medical Research Agency!

We are thrilled to share the exciting news that Professor Wojciech Fendler, the Head of our Department, has been elected as the President of the Polish Medical Research Agency. This prestigious position recognizes Professor Fendler’s significant contributions to medical field, and his leadership within the academic community. For further details on the appointment, click here […]

“Clinical Trials: Practice, Law, Ethics” – A Collaborative Effort with Our Department!

We are excited to announce the release of book in collaboration with our Department, “Clinical Trials: Practice, Law, Ethics.” This comprehensive book offers a wide range of specific information and interdisciplinary knowledge pertinent to the conduct of clinical trials. It covers topics from the history of bioethical issues to strictly operational matters, and delves into […]

Dr Konrad Stawiski leading a project within an international consortium!

We are happy to announce that the miRPOC project (“miRPOC: miRNA as biomarkers in early detection and personalised treatment in ovarian cancer”) has been awarded funding under the ERA PerMed Joint Translational Call 2022, co-financed by the European Commission. This project is conducted within an international research consortium and aims to develop and validate a […]

Dr. Ewelina Perdas has been awarded the Bekker NAWA Program scholarship!

We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]

Dr Stawiski joins ESTRO AI in RT Focus Group!

Dr. Konrad Stawiski has been elected as a member of the international working group focusing on artificial intelligence in oncological radiotherapy within the European Society for Radiotherapy and Oncology. Dr. Konrad Stawiski’s term will last for 3 years. The task of the working groups is to assist in developing clinical and technical guidelines, provide advice […]

Prof. Wojciech Fendler in Scientific Committees of the Polish Academy of Sciences!

We are pleased to announce that Prof. Wojciech Fendler has been elected as a member of the Scientific Committees of the Polish Academy of Sciences in the Committee on Clinical Sciences and the Committee on Human Genetics and Molecular Pathology. Congratulations! More information and full lists of the Committees’ composition are available here.

Our new publication in the prestigious journal Science Advances!

Despite significant progress in oncology in recent decades, only about 50% of patients with invasive bladder cancer (MIBC) affecting the muscle layer, survive five years after diagnosis. New hope comes from the combination of radiochemotherapy with the rapidly advancing field of immunotherapy. A member of our team, and a specialist in oncological radiotherapy from the […]

Open recruitment for the Research Team of the POLONEZ BIS 3 – ENDOVO Project

We cordially invite applications from young ambitious scientists for the project “Identification of Angiogenesis and Metabolic Markers in Endometriosis and its Associated Ovarian Epithelial Cancer using Photoacoustic Imaging and Data Exploration (ENDOVO),” under the supervision of Dr. Monika Golińska, funded by the POLONEZ BIS 3 program of the National Science Centre for the years 2023-2025. […]

Scroll to top